Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04730999
Title Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer (CeLEBrATE)
Acronym CeLEBrATE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Oncologico Italiano di Ricerca Clinica
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.